Fig. 4.

Strategies for drug targeting to the infected RBC. (1) Passive drug targeting achieved by conventional nanicarriers such as liposome, polymeric nanoparticles, and long-circulating nanocarriers (PEGylated), (2) active drug targeting which is achieved by the nanocarriers modified with the ligands suvh as carbohydrate, protein, peptide, or antibodies